Camellia PLC Refocussing investments & Bardsley England update (7045Y)
04 Gennaio 2024 - 5:00PM
UK Regulatory
TIDMCAM
RNS Number : 7045Y
Camellia PLC
04 January 2024
4 January 2024
Camellia Plc
(the "Company" or the "Group")
Update on refocussing investments and Bardsley England
Progress in refocussing investments
BF&M
As announced on 6 June 2023, we agreed the sale of our 37%
holding in BF&M to Bermuda Life Insurance Company Limited, a
subsidiary of Argus Group Holdings Limited ("Argus") for a cash
consideration of $100m (the "Sale"), conditional on receipt of a
number of regulatory and tax approvals.
Following the announcement of this proposed disposal, BF&M's
board implemented a shareholder rights agreement, the objective of
which was to act as a 'poison pill' in the event of any new
shareholder seeking to register a more than 15% shareholding
without BF&M's consent. This shareholder rights agreement has
since been removed. However, BF&M has since separately
announced a partnership with Equilibria Capital Management Limited
(Argus' major shareholder) under which Equilibria will grant
BF&M an exclusive option to acquire a 13.7% stake in Argus. As
part of this partnership, BF&M has also committed to a
significant investment in a dedicated Equilibria investment fund
which will include the initial investment in respect of a 16.3%
stake in Argus.
These developments have impacted the anticipated timetable for
regulatory approvals for the Sale such that we now expect it to be
delayed into Q1 2024.
Collections
In line with the stated strategy, the Company sold a significant
number of items from the manuscript collection, predominantly at
auction in December 2023, generating net proceeds of approximately
GBP2.6 million. A gain on disposal of approximately GBP1.9 million
will be reflected in the 2023 results.
Bardsley England
Since acquisition and as previously announced, Bardsley England
has consistently failed to perform to expectation incurring
significant losses in each year. A combination of factors has
contributed to this unacceptable outcome. These include above
inflation increases in labour costs, due to government policy on
pay for seasonal workers which had a consequent impact on wage
rates for permanent workers. In addition, very high inflation in
electricity, fertiliser, chemicals and fuel costs as a result of
the Ukraine war had an indirect inflationary impact on other costs.
Although consumers have experienced significant food inflation, key
retail customers have continued to resist any meaningful selling
price increases. The sales programme for the Bardsley's 2023
harvest is in place but unfortunately prices achieved are
insufficient to make any meaningful headway into the cost inflation
experienced over the last two years. Attempts to mitigate cost
increases through the restructurings undertaken in 2021 and again
in early 2023 have had limited impact.
Most of the UK top fruit sector is experiencing di culties and
many producers have removed orchards, discontinued planting and in
the worst cases stopped farming. Similar cases are reported in the
wider fresh produce sector.
Considering the trading environment, and despite the significant
efforts made by Bardsley's management to increase efficiency and to
explore new more profitable markets, it has become apparent that
there is no reasonable turnaround plan which would result in a
profitable business. The losses are unsustainable and as a result
Bardsley England is now consulting with its employees on a proposed
orderly wind down of the business. Customer's programmes for the
2023 harvest will be supported with closure of all operations
expected in Q2 2024. In the meantime, Bardsley England is seeking
to maximise the value realisation from its assets.
An update on Group trading will be provided when
appropriate.
This announcement contains inside information for the purposes
of the UK Market Abuse Regulation.
Enquiries
Camellia Plc 01622 746655
Byron Coombs, CEO
Susan Walker, Chief Financial Officer
Panmure Gordon 020 7886 2500
Nominated Adviser and Broker
Emma Earl
Rupert Dearden
H/Advisors Maitland
PR
William Clutterbuck 07785 292617
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUSOVRSUUARAR
(END) Dow Jones Newswires
January 04, 2024 11:00 ET (16:00 GMT)
Grafico Azioni Camellia (LSE:CAM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Camellia (LSE:CAM)
Storico
Da Gen 2024 a Gen 2025